How to Assess Premature Death Risk in Borderline Personality Disorder
How should clinicians assess risk for premature non-suicide death in patients with borderline personality disorder based on this study?
For patients with borderline personality disorder, long-term mortality prevention should not focus only on suicide. Over 24 years in this cohort, non-suicide death was more common than suicide, and several baseline clinical and medical vulnerability markers were associated with quicker time-to-death.
-
Recognize premature non-suicide death as a core outcome
Start by treating medical mortality risk as a routine part of BPD management rather than a secondary issue. In this cohort, 14.0% of borderline patients died of non-suicide causes over follow-up, compared with 5.9% who died by suicide.
-
Screen for the strongest independent mortality markers
Give particular attention to male patients and to those with a more extensive prior psychiatric hospitalization history. In multivariate analyses, male sex predicted premature non-suicide death with a hazard ratio of 3.56 and P = .003, and more prior psychiatric hospitalizations predicted it with a hazard ratio of 2.93 and P < .001.
-
Document additional baseline vulnerability factors
Assess socioeconomic status, government disability status, history of drug use disorder, number of psychiatric medications, and obesity. In bivariate analyses, lower socioeconomic status, being on government disability, drug use disorder history, greater number of psychiatric medications, and obese-range body mass index of 30 or higher were all significant predictors of premature death not due to suicide.
-
Review the main categories of non-suicide mortality
Use the study's cause-of-death pattern to focus clinical review on the medical risks most represented in this population. The most common non-suicide causes of death across groups were cardiovascular causes, followed by substance-related complications, cancer, and accidents.
-
Determine whether the patient has achieved recovery
Assess recovery using the study's definition: at least one 2-year period with remission from the primary personality disorder, at least one emotionally sustaining relationship, and consistent, competent full-time work or school functioning, including being a houseperson. Most borderline patients who died by suicide or by other causes had never achieved recovery before death, with 87.5% in each group unrecovered.
-
Target modifiable risks highlighted by the study
When patients show elevated mortality risk, prioritize intervention on health behaviors, psychiatric medication burden, and substance abuse treatment referral. The discussion specifically identifies earlier targeting of diet, physical activity, smoking, reducing the number of psychiatric medications, and referral to substance abuse treatment as clinically relevant areas informed by the predictive findings.
Clinical Considerations
- Only male sex and prior psychiatric hospitalizations remained significant in multivariate analysis, so the other baseline factors should be interpreted as bivariate signals rather than independent predictors.
- Most participants were initially psychiatric inpatients and were involved in ongoing outpatient psychotherapy and/or psychopharmacologic treatment, which may limit generalizability.
- The study examined a limited set of predictors, so this is not a complete mortality risk model.
- Between-group differences in time-to-death versus personality-disordered comparison subjects were not statistically significant in this sample.
Bottom Line
In borderline personality disorder, mortality assessment should routinely include non-suicide death risk, with special attention to male sex, extensive prior psychiatric hospitalization, unrecovered status, obesity, drug use disorder, and psychiatric medication burden.
